ChiCTR2200056461 版本V1.0 版本创建时间2022/02/06 15:01:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200056461 

最近更新日期:

Date of Last Refreshed on:

2022-02-06 15:00:31 

注册时间:

Date of Registration:

2022-02-06 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

此为补注册,需在www.medresman.org上建立项目、审核原始数据并公示后才能补注册 冠心病PCI患者围手术期营养状况评估

Public title:

Evaluation of perioperative nutritional status in patients with coronary heart disease after PCI

注册题目简写:

English Acronym:

研究课题的正式科学名称:

冠心病PCI患者围手术期营养状况评估

Scientific title:

Evaluation of perioperative nutritional status in patients with coronary heart disease after PCI

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

曹楚雄 

研究负责人:

王建 

Applicant:

Cao Chuxiong 

Study leader:

Wang Jian 

申请注册联系人电话:

Applicant telephone:

17763742571

研究负责人电话:

Study leader's
telephone:

023-68774836

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1045503606@qq.com

研究负责人电子邮件:

Study leader's E-mail:

wangjian_1996@aliyun.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国重庆市沙坪坝区新桥正街183号

研究负责人通讯地址:

中国重庆市沙坪坝区新桥正街183号

Applicant address:

183 Xinqiao Main Street, Shapingba District, Chongqing, China

Study leader's address:

183 Xinqiao Main Street, Shapingba District, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陆军军医大学第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Army Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-研第024-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军军医大学第二附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Second Affiliated Hospital of Army Military University,PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2021-03-12 00:00:00

伦理委员会联系人:

刘丹

Contact Name of the ethic committee:

Liu Dan

伦理委员会联系地址:

中国重庆市沙坪坝区新桥正街183号陆军军医大学第二附属医院药学部三楼伦理委员会办公室

Contact Address of the ethic committee:

Office of medical ethical committee, 3rd floor, pharmacy department, the second affiliated hospital of army medical university, 183 Xinqiao Main Street, Shapingba District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

陆军军医大学第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Army Medical University

研究实施负责(组长)单位地址:

中国重庆市沙坪坝区新桥正街183号

Primary sponsor's address:

183 Xinqiao Main Street, Shapingba District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军军医大学第二附属医院

具体地址:

中国重庆市沙坪坝区新桥正街183号

Institution
hospital:

The Second Affiliated Hospital of Army Medical University

Address:

183 Xinqiao Main Street, Shapingba District, Chongqing, China

经费或物资来源:

陆军军医大学第二附属医院临床科研项目

Source(s) of funding:

the Clinical Scientific Research Project of the second affiliated hospital of Army Medical University

研究疾病:

冠心病  

Target disease:

Coronary heart disease (CHD)

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

通过营养状况评估结果分析冠心病PCI手术患者围手术期日常能量、蛋白质及主要矿物质、维生素摄入是否满足日常需求,从而评估冠心病PCI手术患者群体日常摄入水平,统计冠心病PCI手术围手术期人群营养不良发生率。  

Objectives of Study:

Nutritional status assessment results were used to analyze whether the daily intake of energy, protein, major minerals and vitamins in coronary heart disease patients undergoing PCI during the perioperative period met their daily needs, so as to evaluate the daily intake level of coronary heart disease patients undergoing PCI, and calculate the incidence of malnutrition in coronary heart disease patients undergoing PCI during the perioperative period.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄18-90岁;②诊断为冠状动脉粥样硬化性心脏病并在我院心内科住院治疗,拟行经桡动脉PCI手术治疗;③具有基本交流能力,本人同意并签署知情同意书。

Inclusion criteria

① 18-90 years old;② He was diagnosed with coronary atherosclerotic heart disease and hospitalized in the department of Cardiology of our hospital. PCI was planned to be performed via radial artery;(3) With basic communication skills, I agree and sign the informed consent.

排除标准:

①严重心肺及肝肾功能不全、或全身状况较差不能耐受手术者;②妊娠或哺乳期妇女;③安装有起搏器的心血管疾病患者; ④存在严重认知障碍或精神疾病,无法配合调查。

Exclusion criteria:

① Patients with severe heart, lung, liver and kidney insufficiency or poor general condition cannot tolerate surgery;② Pregnant or lactating women;(3) patients with cardiovascular diseases with pacemakers;④ With severe cognitive impairment or mental illness, unable to cooperate with the investigation.

研究实施时间:

Study execute time:

From 2021-04-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-04-01 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

120

Group:

case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军军医大学第二附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Second Affiliated Hospital of Army Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

相位角

指标类型:

主要指标

Outcome:

Phase Angle

Type:

Primary indicator

测量时间点:

PCI手术前

测量方法:

inbody S10人体成分分析仪

Measure time point of outcome:

before the PCI surgery

Measure method:

inbody S10 Body composition analyzer

指标中文名:

NRS-2002评分

指标类型:

主要指标

Outcome:

NRS - 2002 score

Type:

Primary indicator

测量时间点:

PCI手术前

测量方法:

调查问卷

Measure time point of outcome:

before the PCI surgery

Measure method:

The questionnaire

指标中文名:

营养素摄入情况

指标类型:

主要指标

Outcome:

Nutrient intake

Type:

Primary indicator

测量时间点:

PCI术前和术后

测量方法:

调查问卷

Measure time point of outcome:

before and after the PCI surgery

Measure method:

The questionnaire

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

无标本

组织:

Sample Name:

No specimens are taken

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究未进行分组

Randomization Procedure (please state who generates the random number sequence and by what method):

The study was not grouped

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表和电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF and EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-02-06 15:00:31